Acalabrutinib 100mg cap

About Acalabrutinib 100mg cap

Acaone 100mg Capsule is used in the treatment of blood cancer. It is given to patients aged more than 18 years who have received at least one prior treatment for their cancer. It is unknown if this drug is safe and effective in children.

Acaone 100mg Capsule is taken orally, preferably with food or between meals. It should be used in the dose and duration prescribed by your doctor. It is advised to take this medicine at a fixed time and for as long as the doctor prescribes to avoid missing a dose. It may take several weeks or months for you to see or feel the benefits.

The most common side effects of Acaone 100mg Capsule include anemia, neutropenia, upper respiratory tract infection, thrombocytopenia, headache, diarrhea, and musculoskeletal pain. If these bother you or appear serious, let your doctor know as they might suggest ways of reducing or preventing these side effects.

Inform your doctor if you have a medical history of bleeding disorders, heart or liver disease, radiation treatment, or any infection. The risk of bleeding may increase if the patient is taking a blood thinner medicine along with Acaone 100mg Capsule. Many other medicines can affect or be affected by this medicine, so let your doctor know of all the medications you are using. Inform the doctor immediately if unusual bruising or bleeding or dark, tarry, or bloody stools and sore throat are noticed.

This medicine is known to reduce the number of blood cells in your blood, thereby increasing the susceptibility to infections. Regular blood tests are required to check the blood cell count along with the kidneys, liver, and heart functions during the treatment with this medicine. The use of effective contraception by both males and females during the treatment is important to avoid pregnancy.

Targeted Oncology Solution

Acalabrutinib 100mg capsules offer advanced treatment for selected B-cell malignancies such as mantle cell lymphoma and chronic lymphocytic leukemia. By selectively inhibiting Bruton tyrosine kinase, it addresses cancer progression at the molecular level, contributing to improved therapeutic outcomes.


Convenient Oral Administration

This formulation is designed for oral intake, providing ease of use for patients without the need for intravenous administration. The medication should be taken as prescribed, with each capsule offering a consistent dose for reliable therapeutic action.


Safe and Secure Handling

To maintain effectiveness, store Acalabrutinib capsules at temperatures below 30C, protected from moisture and light. Adhering to these storage guidelines and monitoring for known risks such as bleeding, infection, and cytopenias enhances patient safety throughout treatment.